(Well, New York Times) A drug used to treat rheumatoid arthritis may have benefits against Alzheimer’s disease, researchers report.
Rheumatoid arthritis is an autoimmune disease believed to be driven in part by tumor necrosis factor, or T.N.F., a protein that promotes inflammation. Drugs that block T.N.F., including an injectable drug called etanercept, have been used to treat rheumatoid arthritis for many years.
T.N.F. is also elevated in the cerebrospinal fluid of Alzheimer’s patients…
[U]nlike patients treated with five other rheumatoid arthritis drugs, those who had been treated with etanercept showed a significantly reduced risk for Alzheimer’s disease.[Click the title, above, to post a comment.]